Paravertebral Block for Breast Surgery

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00131170

Enrollment

Registered

2005-08-17

Start date

2005-09-30

Completion date

2006-09-30

Last updated

2007-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

The effect of paravertebral block in combination with general anaesthesia is studied in a double blind fashion.

Detailed description

Patients having surgery for breast cancer receive a paravertebral blockade at C8-Th4 with either Naropin 0.5% or saline. General anaesthesia is then provided with laryngeal mask intubation, propofol infusion and fentanyl i.v. as needed. The effect on postoperative pain (\[VAS\] and fentanyl PCA doses taken) and postoperative nausea and vomiting is recorded.

Interventions

PROCEDUREparavertebral block

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Breast surgery

Exclusion criteria

* Infections * Coagulation disorder * Allergy

Design outcomes

Primary

Measure	Time frame
Nausea and vomiting 2 hours postoperatively, and 1 and 2 days postoperatively	2 days

Secondary

Measure	Time frame
Dosage of analgesic	1 day

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026